MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy

被引:25
作者
Song, Yongan [1 ]
Kelava, Leonardo [2 ]
Kiss, Istvan [1 ]
机构
[1] Univ Pecs, Med Sch, Dept Publ Hlth Med, Szigeti Str 12, H-7624 Pecs, Hungary
[2] Univ Pecs, Inst Translat Med, Med Sch, Dept Thermophysiol, Sziget Str 12, H-7624 Pecs, Hungary
基金
英国科研创新办公室;
关键词
miRNA; LUAD; tumor suppressor; oncogenic; diagnosis; prognosis; therapy; FACTOR RECEPTOR MUTATIONS; SQUAMOUS-CELL CARCINOMA; MICRORNA EXPRESSION; TUMOR-GROWTH; SIGNALING PATHWAY; NUCLEAR EXPORT; CANCER; PROMOTES; METASTASIS; BIOMARKERS;
D O I
10.3390/ijms241713302
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lung cancer has emerged as a significant public health challenge and remains the leading cause of cancer-related mortality worldwide. Among various types of lung malignancies, lung adenocarcinoma (LUAD) stands as the most prevalent form. MicroRNAs (miRNAs) play a crucial role in gene regulation, and their involvement in cancer has been extensively explored. While several reviews have been published on miRNAs and lung cancer, there remains a gap in the review regarding miRNAs specifically in LUAD. In this review, we not only highlight the potential diagnostic, prognostic, and therapeutic implications of miRNAs in LUAD, but also present an inclusive overview of the extensive research conducted on miRNAs in this particular context.
引用
收藏
页数:25
相关论文
共 133 条
[1]   Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway [J].
An, Yunxia ;
Zhang, Qianqian ;
Li, Xiaoliang ;
Wang, Zheng ;
Li, Ying ;
Tang, Xueyi .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 108 :1845-1855
[2]   Lung Cancer 2020 Epidemiology, Etiology, and Prevention [J].
Bade, Brett C. ;
Dela Cruz, Charles S. .
CLINICS IN CHEST MEDICINE, 2020, 41 (01) :1-+
[3]   Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs [J].
Bohnsack, MT ;
Czaplinski, K ;
Görlich, D .
RNA, 2004, 10 (02) :185-191
[4]   Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma [J].
Boldrini, Laura ;
Giordano, Mirella ;
Niccoli, Cristina ;
Melfi, Franca ;
Lucchi, Marco ;
Mussi, Alfredo ;
Fontanini, Gabriella .
CANCER CELL INTERNATIONAL, 2017, 17
[5]   miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1 [J].
Cao, Minghui ;
Hou, Dongxia ;
Liang, Hongwei ;
Gong, Fei ;
Wang, Yilei ;
Yan, Xin ;
Jiang, Xiaohong ;
Wang, Chen ;
Zhang, Junfeng ;
Zen, Ke ;
Zhang, Chen-Yu ;
Chen, Xi .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) :1013-1024
[6]   Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression [J].
Chen, Limo ;
Yi, Xiaohui ;
Goswami, Sangeeta ;
Ahn, Young-Ho ;
Roybal, Jonathon D. ;
Yang, Yongbin ;
Diao, Lixia ;
Peng, Di ;
Peng, David ;
Fradette, Jared J. ;
Wang, Jing ;
Byers, Lauren A. ;
Kurie, Jonathan M. ;
Ullrich, Stephen E. ;
Qin, F. Xiao-Feng ;
Gibbons, Don L. .
ONCOIMMUNOLOGY, 2016, 5 (11)
[7]   Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery [J].
Chen, Wenqi ;
Liu, Yong ;
Liang, Xiao ;
Huang, Yu ;
Li, Quanshun .
ACTA BIOMATERIALIA, 2017, 57 :238-250
[8]   MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1 [J].
Cho, William C. S. ;
Chow, Andrew S. C. ;
Au, Joseph S. K. .
RNA BIOLOGY, 2011, 8 (01) :125-131
[9]   Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation [J].
Cho, William C. S. ;
Chow, Andrew S. C. ;
Au, Joseph S. K. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) :2197-2206
[10]   PDL1 Regulation by p53 via miR-34 [J].
Cortez, Maria Angelica ;
Ivan, Cristina ;
Valdecanas, David ;
Wang, Xiaohong ;
Peltier, Heidi J. ;
Ye, Yuping ;
Araujo, Luiz ;
Carbone, David P. ;
Shilo, Konstantin ;
Giri, Dipak K. ;
Kelnar, Kevin ;
Martin, Desiree ;
Komaki, Ritsuko ;
Gomez, Daniel R. ;
Krishnan, Sunil ;
Calin, George A. ;
Bader, Andreas G. ;
Welsh, James W. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (01)